Literature DB >> 11120854

Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.

H Ali1, J Ahamed, C Hernandez-Munain, J L Baron, M S Krangel, D D Patel.   

Abstract

Chemoattractants are thought to be the first mediators generated at sites of bacterial infection. We hypothesized that signaling through G protein-coupled chemoattractant receptors may stimulate cytokine production. To test this hypothesis, a human mast cell line (HMC-1) that normally expresses receptors for complement components C3a and C5a at low levels was stably transfected to express physiologic levels of fMLP receptors. We found that fMLP, but not C3a or C5a, induced macrophage inflammatory protein (MIP)-1ss (CCL4) and monocyte chemoattractant protein-1 (CCL2) mRNA and protein. Although fMLP stimulated both sustained Ca(2+) mobilization and phosphorylation of extracellular signal-regulated kinase (ERK), these responses to C3a or C5a were transient. However, transient expression of C3a receptors in HMC-1 cells rendered the cells responsive to C3a for sustained Ca(2+) mobilization and MIP-1ss production. The fMLP-induced chemokine production was blocked by pertussis toxin, PD98059, and cyclosporin A, which respectively inhibit G(i)alpha activation, mitgen-activated protein kinase kinase-mediated ERK phosphorylation, and calcineurin-mediated activation of NFAT. Furthermore, fMLP, but not C5a, stimulated NFAT activation in HMC-1 cells. These data indicate that chemoattractant receptors induce chemokine production in HMC-1 cells with a selectivity that depends on the level of receptor expression, the length of their signaling time, and the synergistic interaction of multiple signaling pathways, including extracellular signal-regulated kinase phosphorylation, sustained Ca(2+) mobilization and NFAT activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120854     DOI: 10.4049/jimmunol.165.12.7215

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  [New immunosuppressive agents for treating psoriasis].

Authors:  S Ortiz-Urda; K Rappersberger
Journal:  Hautarzt       Date:  2003-02-18       Impact factor: 0.751

Review 2.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

3.  Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization.

Authors:  Hariharan Subramanian; Kshitij Gupta; Qiang Guo; Ryan Price; Hydar Ali
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

4.  Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis.

Authors:  Jeong-Eun Kim; Ji Man Han; Cho Rong Park; Kum-Joo Shin; Curie Ahn; Jae Young Seong; Jong-Ik Hwang
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

5.  IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation.

Authors:  Matthew R Silver; Alexander Margulis; Nancy Wood; Samuel J Goldman; Marion Kasaian; Divya Chaudhary
Journal:  Inflamm Res       Date:  2009-09-18       Impact factor: 4.575

6.  Abnormal Microglia and Enhanced Inflammation-Related Gene Transcription in Mice with Conditional Deletion of Ctcf in Camk2a-Cre-Expressing Neurons.

Authors:  Bryan E McGill; Ruteja A Barve; Susan E Maloney; Amy Strickland; Nicholas Rensing; Peter L Wang; Michael Wong; Richard Head; David F Wozniak; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2017-11-13       Impact factor: 6.167

7.  Distinct roles of Ca2+ mobilization and G protein usage on regulation of Toll-like receptor function in human and murine mast cells.

Authors:  Asifa K Zaidi; Elden Retna Raj B Thangam; Hydar Ali
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

8.  PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells.

Authors:  Hariharan Subramanian; Sakeen W Kashem; Sarah J Collington; Hongchang Qu; John D Lambris; Hydar Ali
Journal:  Mol Pharmacol       Date:  2011-03-11       Impact factor: 4.436

9.  Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity.

Authors:  Karen P Fong; Cinthia M F Pacheco; Linda L Otis; Somesh Baranwal; Irene R Kieba; Gerald Harrison; Elliot V Hersh; Kathleen Boesze-Battaglia; Edward T Lally
Journal:  Cell Microbiol       Date:  2006-07-07       Impact factor: 3.715

Review 10.  Regulation of G-protein-coupled signaling pathways in allergic inflammation.

Authors:  Kirk M Druey
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.